Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2015 2
2017 1
2018 4
2019 7
2020 11
2021 12
2022 15
2023 10
2024 4

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

60 results

Results by year

Filters applied: . Clear all
Page 1
Atezolizumab plus bevacizumab and chemotherapy for metastatic, persistent, or recurrent cervical cancer (BEATcc): a randomised, open-label, phase 3 trial.
Oaknin A, Gladieff L, Martínez-García J, Villacampa G, Takekuma M, De Giorgi U, Lindemann K, Woelber L, Colombo N, Duska L, Leary A, Godoy-Ortiz A, Nishio S, Angelergues A, Rubio MJ, Fariñas-Madrid L, Yamaguchi S, Lorusso D, Ray-Coquard I, Manso L, Joly F, Alarcón J, Follana P, Romero I, Lebreton C, Pérez-Fidalgo JA, Yunokawa M, Dahlstrand H, D'Hondt V, Randall LM; ENGOT-Cx10–GEICO 68-C–JGOG1084–GOG-3030 Investigators. Oaknin A, et al. Lancet. 2024 Jan 6;403(10421):31-43. doi: 10.1016/S0140-6736(23)02405-4. Epub 2023 Dec 1. Lancet. 2024. PMID: 38048793 Clinical Trial.
Editorial: Endocrine aspects of gynaecological cancers.
Czogalla B, Montt-Guevara MM, Jeschke U. Czogalla B, et al. Front Endocrinol (Lausanne). 2024 Feb 9;15:1377378. doi: 10.3389/fendo.2024.1377378. eCollection 2024. Front Endocrinol (Lausanne). 2024. PMID: 38405147 Free PMC article. No abstract available.
Treatment and survival of patients with malignant ovarian sex cord-stromal cell tumours: An analysis of the Arbeitsgemeinschaft für Gynäkologische Onkologie (AGO) study group CORSETT database.
Klar M, Plett H, Harter P, Heitz F, Kommoss S, Hartkopf AD, Grube M, Roser E, Sehouli J, Braicu I, Czogalla B, Burges A, Bossart M, Hasanov MF, Link T, Staebler A, Mayr D, Buderath P, Hasenburg A. Klar M, et al. Among authors: czogalla b. J Surg Oncol. 2023 Jul;128(1):111-118. doi: 10.1002/jso.27248. Epub 2023 Mar 28. J Surg Oncol. 2023. PMID: 36975108 Review.
Vitamin D and VDR in Gynecological Cancers-A Systematic Review.
Deuster E, Jeschke U, Ye Y, Mahner S, Czogalla B. Deuster E, et al. Among authors: czogalla b. Int J Mol Sci. 2017 Nov 4;18(11):2328. doi: 10.3390/ijms18112328. Int J Mol Sci. 2017. PMID: 29113037 Free PMC article. Review.
Characterization and prognostic impact of ACTBL2-positive tumor-infiltrating leukocytes in epithelial ovarian cancer.
Topalov NE, Mayr D, Kuhn C, Leutbecher A, Scherer C, Kraus FBT, Tauber CV, Beyer S, Meister S, Hester A, Kolben T, Burges A, Mahner S, Trillsch F, Kessler M, Jeschke U, Czogalla B. Topalov NE, et al. Among authors: czogalla b. Sci Rep. 2023 Dec 18;13(1):22620. doi: 10.1038/s41598-023-49286-9. Sci Rep. 2023. PMID: 38114558 Free PMC article.
Genetics and beyond: Precision Medicine Real-World Data for Patients with Cervical, Vaginal or Vulvar Cancer in a Tertiary Cancer Center.
Kraus FBT, Sultova E, Heinrich K, Jung A, Westphalen CB, Tauber CV, Kumbrink J, Rudelius M, Klauschen F, Greif PA, König A, Chelariu-Raicu A, Czogalla B, Burges A, Mahner S, Wuerstlein R, Trillsch F. Kraus FBT, et al. Among authors: czogalla b. Int J Mol Sci. 2024 Feb 16;25(4):2345. doi: 10.3390/ijms25042345. Int J Mol Sci. 2024. PMID: 38397025 Free PMC article.
Involvement of ILR4α and TLR4 in miscarriages.
Kolben TM, Rogatsch E, Hester A, Kuhn C, Schmoeckel E, Czogalla B, Mahner S, Jeschke U, Kolben T. Kolben TM, et al. Among authors: czogalla b. J Reprod Immunol. 2019 Feb;131:36-43. doi: 10.1016/j.jri.2018.12.001. Epub 2019 Jan 8. J Reprod Immunol. 2019. PMID: 30639993 Clinical Trial.
Presence of regulatory T-cells in endometrial cancer predicts poorer overall survival and promotes progression of tumor cells.
Kolben T, Mannewitz M, Perleberg C, Schnell K, Anz D, Hahn L, Meister S, Schmoeckel E, Burges A, Czogalla B, Hester A, Mahner S, Kessler M, Jeschke U, Corradini S, Trillsch F, Beyer S. Kolben T, et al. Among authors: czogalla b. Cell Oncol (Dordr). 2022 Dec;45(6):1171-1185. doi: 10.1007/s13402-022-00708-2. Epub 2022 Sep 13. Cell Oncol (Dordr). 2022. PMID: 36098901 Free PMC article.
60 results